USPH vs AFCG vs CCRN

For growth investors, U.

S. Physical Therapy, Inc. (USPH) is the stronger pick with 16. 3% revenue growth year-over-year, versus -39. 6% for Advanced Flower Capital Inc. (AFCG). U. S. Physical Therapy, Inc. (USPH) offers the better valuation at 51. 8x trailing P/E (20. 6x forward), making it the more compelling value choice. Analysts rate U. S. Physical Therapy, Inc. (USPH) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, U.

S. Physical Therapy, Inc. is actually cheaper at 20. 6x.

Over the past 5 years, U.

S. Physical Therapy, Inc. (USPH) delivered a total return of -29. 7%, compared to -45. 0% for Advanced Flower Capital Inc. (AFCG). Over 10 years, the gap is even starker: USPH returned +22. 6% versus AFCG's -42. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Cross Country Healthcare, Inc.

(CCRN) is the lower-risk stock at 0. 78β versus Advanced Flower Capital Inc. 's 1. 86β — meaning AFCG is approximately 138% more volatile than CCRN relative to the S&P 500. On balance sheet safety, Cross Country Healthcare, Inc. (CCRN) carries a lower debt/equity ratio of 1% versus 55% for U. S. Physical Therapy, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), U.

S. Physical Therapy, Inc. (USPH) is pulling ahead at 16. 3% versus -39. 6% for Advanced Flower Capital Inc. (AFCG). On earnings-per-share growth, the picture is similar: U. S. Physical Therapy, Inc. grew EPS -22. 8% year-over-year, compared to -565. 9% for Cross Country Healthcare, Inc.. Over a 3-year CAGR, USPH leads at 12. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

U.

S. Physical Therapy, Inc. (USPH) is the more profitable company, earning 1. 9% net margin versus -66. 0% for Advanced Flower Capital Inc. — meaning it keeps 1. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: USPH leads at 10. 3% versus -43. 6% for AFCG. At the gross margin level — before operating expenses — AFCG leads at 90. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, U.

S. Physical Therapy, Inc. (USPH) trades at 20. 6x forward P/E versus 133. 8x for Cross Country Healthcare, Inc. — 113. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for USPH: 38. 6% to $102. 00.

In this comparison, AFCG (31.

3% yield), USPH (2. 4% yield) pay a dividend. CCRN does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, U.

S. Physical Therapy, Inc. (USPH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 93), 2. 4% yield). Advanced Flower Capital Inc. (AFCG) carries a higher beta of 1. 86 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (USPH: +22. 6%, AFCG: -42. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (USPH (Healthcare) and AFCG (Real Estate) and CCRN (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: USPH is a small-cap high-growth stock; AFCG is a small-cap income-oriented stock; CCRN is a small-cap quality compounder stock. USPH, AFCG pay a dividend while CCRN does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.